24 mEq
Trade Name
Sibnayal
Prolonged-release granules
Request Type
Registration
Drug Type
New Drug
Approval Date
SFDA Approved Use
Sibnayal® is intended for the treatment of distal renal tubular acidosis (dRTA) in adults, adolescents and children aged one year and older.